We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pharmacist Group Voices “Serious” Concerns With State Biosimilar Bills
Pharmacist Group Voices “Serious” Concerns With State Biosimilar Bills
June 18, 2013
State-level efforts to hinder substitution of biosimilar interchangeable products are premature and unfounded, a U.S. pharmacist group says, as Oregon and Delaware join a growing list of states moving to advance legislation that restricts the substitution of biosimilars for brand biologics.